INSR and Alzheimer disease: Models of brain-diabetes often exhibit abnormalities similar to AD, and insulin deficiency and resistance are potential mediators of the neurodegenerative process, with associated disfunction of insulin receptor expression decreasing in an AD-stage dependent manner; deficiency in insulin/IGF signaling, which leads to deficiencies in energy metabolism, inflammation, and oxidative stress [216].